SPRY | ARS Pharmaceuticals, Inc. Annual & Quarterly

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	233.18 Million	281.43 Million	61.44 Million	26.4 Million	15.64 Million	27.54 Million
Total Current Assets	231.56 Million	277.7 Million	60.73 Million	26.38 Million	10.52 Million	20.77 Million
Cash And Short Term Investments	228.36 Million	274.38 Million	60.06 Million	24.52 Million	9.97 Million	20.16 Million
Cash and Cash Equivalents	70.97 Million	210.51 Million	60.06 Million	24.52 Million	9.97 Million	20.16 Million
Short Term Investments	157.38 Million	63.86 Million	-	-	-	-
Net Receivables	795 Thousand	1 Million	1000.00	384 Thousand	-	-
Inventory	-	-1 Million	-6.78 Million	-2.61 Million	-	-
Other Current Assets	2.4 Million	3.31 Million	7.44 Million	4.08 Million	552 Thousand	618 Thousand
Total Non-Current Assets	1.62 Million	3.73 Million	716 Thousand	25 Thousand	5.11 Million	6.76 Million
Net PPE	824 Thousand	774 Thousand	693 Thousand	23 Thousand	4.56 Million	6.01 Million
Good Will And Intangible Assets	617 Thousand	-	-	-	-	-
Good Will	-	-	-	-	-	-
Intangible Assets	617 Thousand	-	-	-	-	-
Long-Term Investments	-	-	64.78 Million	350 Thousand	550 Thousand	750 Thousand
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	184 Thousand	2.96 Million	-64.75 Million	-348 Thousand	-	-
Other Assets	-	-	-	-	-	-
Total Liabilities	2.42 Million	8.54 Million	92.71 Million	40.45 Million	21.25 Million	9.35 Million
Total Current Liabilities	2.39 Million	5.44 Million	8.18 Million	8.21 Million	17.92 Million	5.14 Million
Account Payables	759 Thousand	1.65 Million	1.78 Million	1.21 Million	3.51 Million	775 Thousand
Tax Payables	4000.00	174 Thousand	-	-	-	-
Short Term Debt	237 Thousand	230 Thousand	3.62 Million	2.55 Million	12.29 Million	3.52 Million
Deferred Revenue	4000.00	283 Thousand	1.45 Million	3.51 Million	-	-
Other Current Liabilities	1.39 Million	3.27 Million	1.32 Million	915 Thousand	2.11 Million	841 Thousand
Total Non Current Liabilities	36.99 Thousand	3.1 Million	84.52 Million	32.24 Million	3.32 Million	4.2 Million
Long-Term Debt	37 Thousand	251 Thousand	5.41 Million	7.46 Million	-	-
Deferred Revenue Non Current	-	2.85 Million	2.99 Million	3.44 Million	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	-1.00	2.85 Million	76.12 Million	27 Thousand	-	-
Other Liabilities	1.00	-	-	-	-	1.00
Total Equity	230.76 Million	272.88 Million	-31.26 Million	-14.05 Million	-5.6 Million	18.19 Million
Stock Holders Equity	230.76 Million	272.88 Million	-31.26 Million	-14.05 Million	-5.6 Million	18.19 Million
Common Stock	10 Thousand	9000.00	257 Thousand	223 Thousand	-	-
Retained Earnings	-131.3 Million	-76.93 Million	-42.25 Million	-22.01 Million	-63.78 Million	-39.82 Million
Accumulated other comprehensive income	49 Thousand	407 Thousand	-326 Thousand	-21.23 Million	-	-
Common Stock Equity	230.76 Million	272.88 Million	-31.26 Million	-14.05 Million	-5.6 Million	18.19 Million
Capital Lease Obligation	37 Thousand	481 Thousand	624 Thousand	2.32 Million	3.32 Million	4.2 Million
Total Investments	157.38 Million	63.86 Million	64.78 Million	350 Thousand	550 Thousand	750 Thousand
Total Debt	274 Thousand	481 Thousand	9.03 Million	10.01 Million	15.62 Million	7.73 Million
Net Debt	-70.69 Million	-210.03 Million	-51.03 Million	-14.5 Million	5.64 Million	-12.42 Million

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	221.96 Million	227.58 Million	233.18 Million	233.18 Million	248.55 Million	258.75 Million
Total Current Assets	220.43 Million	226 Million	231.56 Million	231.56 Million	244.46 Million	255.03 Million
Cash And Short Term Investments	218.74 Million	223.63 Million	228.36 Million	228.36 Million	241.9 Million	252.2 Million
Cash and Cash Equivalents	36.62 Million	56 Million	70.97 Million	70.97 Million	60.53 Million	119.01 Million
Short Term Investments	182.11 Million	167.62 Million	157.38 Million	157.38 Million	181.37 Million	133.19 Million
Net Receivables	564 Thousand	685 Thousand	795 Thousand	795 Thousand	814 Thousand	962 Thousand
Inventory	-	-	-	-	-814 Thousand	-962 Thousand
Other Current Assets	1.12 Million	1.69 Million	2.4 Million	2.4 Million	2.56 Million	2.82 Million
Total Non-Current Assets	1.52 Million	1.57 Million	1.62 Million	1.62 Million	4.09 Million	3.71 Million
Net PPE	782 Thousand	814 Thousand	824 Thousand	824 Thousand	917 Thousand	943 Thousand
Good Will And Intangible Assets	446 Thousand	528 Thousand	617 Thousand	617 Thousand	690 Thousand	138 Thousand
Good Will	-	-	-	-	-	-
Intangible Assets	446 Thousand	528 Thousand	617 Thousand	617 Thousand	690 Thousand	138 Thousand
Long-Term Investments	-	-	-	-	-	-
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	300.99 Thousand	232.99 Thousand	184 Thousand	184 Thousand	2.48 Million	2.63 Million
Other Assets	1.00	1.00	-	-	-	-
Total Liabilities	6.72 Million	3.71 Million	2.42 Million	2.42 Million	11.27 Million	10.2 Million
Total Current Liabilities	6.72 Million	3.71 Million	2.39 Million	2.39 Million	11.18 Million	10.05 Million
Account Payables	3.27 Million	839 Thousand	759 Thousand	759 Thousand	2.96 Million	9.65 Million
Tax Payables	13 Thousand	47 Thousand	4000.00	4000.00	-	82 Thousand
Short Term Debt	160 Thousand	217 Thousand	237 Thousand	237 Thousand	235 Thousand	233 Thousand
Deferred Revenue	13 Thousand	47 Thousand	4000.00	4000.00	-2.96 Million	-9.65 Million
Other Current Liabilities	3.28 Million	2.61 Million	1.39 Million	1.39 Million	10.94 Million	9.82 Million
Total Non Current Liabilities	-	-	36.99 Thousand	36.99 Thousand	92 Thousand	146 Thousand
Long-Term Debt	-	-	37 Thousand	37 Thousand	92 Thousand	146 Thousand
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	-	-	-1.00	-1.00	-	-
Other Liabilities	-	-	1.00	1.00	-	-
Total Equity	215.24 Million	223.86 Million	230.76 Million	230.76 Million	237.28 Million	248.55 Million
Stock Holders Equity	215.24 Million	223.86 Million	230.76 Million	230.76 Million	237.28 Million	248.55 Million
Common Stock	10 Thousand	10 Thousand	10 Thousand	10 Thousand	9000.00	9000.00
Retained Earnings	-154.11 Million	-141.59 Million	-131.3 Million	-131.3 Million	-124.13 Million	-109.26 Million
Accumulated other comprehensive income	-145 Thousand	-124 Thousand	49 Thousand	49 Thousand	-161 Thousand	-180 Thousand
Common Stock Equity	215.24 Million	223.86 Million	230.76 Million	230.76 Million	237.28 Million	248.55 Million
Capital Lease Obligation	160 Thousand	217 Thousand	37 Thousand	37 Thousand	327 Thousand	379 Thousand
Total Investments	182.11 Million	167.62 Million	157.38 Million	157.38 Million	181.37 Million	133.19 Million
Total Debt	160 Thousand	217 Thousand	274 Thousand	274 Thousand	327 Thousand	379 Thousand
Net Debt	-36.46 Million	-55.78 Million	-70.69 Million	-70.69 Million	-60.2 Million	-118.63 Million

Balance Sheet Charts

Microba Life Sciences Limited

MAP

Full Analysis

Annual Balance Sheets
Affymax, Inc.

AFFY

Full Analysis

Annual Balance Sheets
Rover Metals Corp.

ROVR

Full Analysis

Annual Balance Sheets
China United Insurance Service, Inc.

CUII

Full Analysis

Annual Balance Sheets
Westhaven Gold Corp.

WHN

Full Analysis

Annual Balance Sheets
Modi Rubber Limited

MODIRUBBER

Full Analysis

Annual Balance Sheets

Global Stocks Search

ARS Pharmaceuticals, Inc. (SPRY)

Annual Balance Sheets

Balance Sheet Charts

Microba Life Sciences Limited

Affymax, Inc.

Rover Metals Corp.

China United Insurance Service, Inc.

Westhaven Gold Corp.

Modi Rubber Limited